Neuraxis converts $4.94M of convertible notes into 2.07M Series B Preferred shares

Neuraxis, INC

$4,935,001.90 of Preferred Stock Notes automatically converted into 2,073,524 Series B Preferred shares at $2.38/share.
Conversion occurred on Sept 9, 2024 after stockholder approval on Aug 15, 2024 and filing of Certificate of Designation.
Shares issued to Flagstaff International and other accredited investors; exempt from registration under Section 4(a)(2).
Series B Preferred ranks senior to common stock on liquidation, convertible into common at any time.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.